Suivre
Silvia Bua
Titre
Citée par
Citée par
Année
Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids (NSAIDs–CAIs) for the treatment of rheumatoid arthritis
S Bua, L Di Cesare Mannelli, D Vullo, C Ghelardini, G Bartolucci, ...
Journal of medicinal chemistry 60 (3), 1159-1170, 2017
1222017
Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC …
WM Eldehna, MF Abo-Ashour, A Nocentini, RS El-Haggar, S Bua, ...
European journal of medicinal chemistry 162, 147-160, 2019
862019
Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand/isoform matching and selectivity of action
A Bonardi, A Nocentini, S Bua, J Combs, C Lomelino, J Andring, ...
Journal of medicinal chemistry 63 (13), 7422-7444, 2020
782020
Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and …
WM Eldehna, GH Al-Ansary, S Bua, A Nocentini, P Gratteri, A Altoukhy, ...
European Journal of Medicinal Chemistry 127, 521-530, 2017
642017
Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases
A Nocentini, S Bua, CL Lomelino, R McKenna, M Menicatti, G Bartolucci, ...
ACS medicinal chemistry letters 8 (12), 1314-1319, 2017
632017
3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico …
MF Abo-Ashour, WM Eldehna, A Nocentini, A Bonardi, S Bua, HS Ibrahim, ...
European Journal of Medicinal Chemistry 184, 111768, 2019
622019
Structured optical materials controlled by light
S Nocentini, D Martella, C Parmeggiani, S Zanotto, DS Wiersma
Advanced Optical Materials 6 (15), 1800167, 2018
602018
Design and synthesis of novel 1, 3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors
N Lolak, S Akocak, S Bua, M Koca, CT Supuran
Bioorganic Chemistry 77, 542-547, 2018
592018
Discovery of new ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors
N Lolak, S Akocak, S Bua, RKK Sanku, CT Supuran
Bioorganic & medicinal chemistry 27 (8), 1588-1594, 2019
542019
Discovery of β-adrenergic receptors blocker–carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy
A Nocentini, M Ceruso, S Bua, CL Lomelino, JT Andring, R McKenna, ...
Journal of Medicinal Chemistry 61 (12), 5380-5394, 2018
542018
Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1, 3, 5-triazine moieties as potent carbonic anhydrase IX inhibitors
N Lolak, S Akocak, S Bua, CT Supuran
Bioorganic Chemistry 82, 117-122, 2019
522019
Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies
MF Abo-Ashour, WM Eldehna, A Nocentini, HS Ibrahim, S Bua, ...
European Journal of Medicinal Chemistry 157, 28-36, 2018
522018
Discovery of novel 1, 3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors
S Akocak, N Lolak, S Bua, CT Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry 33 (1), 1575-1580, 2018
522018
Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies
MF Abo-Ashour, WM Eldehna, A Nocentini, HS Ibrahim, S Bua, ...
Bioorganic Chemistry 87, 794-802, 2019
512019
Design and synthesis of novel benzenesulfonamide containing 1, 2, 3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors
R Kumar, L Vats, S Bua, CT Supuran, PK Sharma
European journal of medicinal chemistry 155, 545-551, 2018
502018
2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies …
N Chiaramonte, S Bua, M Ferraroni, A Nocentini, A Bonardi, G Bartolucci, ...
European Journal of Medicinal Chemistry 151, 363-375, 2018
472018
Synthesis and biological evaluation of benzenesulphonamide-bearing 1, 4, 5-trisubstituted-1, 2, 3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory …
R Kumar, V Sharma, S Bua, CT Supuran, PK Sharma
Journal of Enzyme Inhibition and Medicinal Chemistry 32 (1), 1187-1194, 2017
452017
Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors
MA Said, WM Eldehna, A Nocentini, A Bonardi, SH Fahim, S Bua, ...
European Journal of Medicinal Chemistry 185, 111843, 2020
442020
Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors
R Kumar, S Bua, S Ram, S Del Prete, C Capasso, CT Supuran, ...
Bioorganic & Medicinal Chemistry 25 (3), 1286-1293, 2017
442017
Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII …
HI Gul, C Yamali, M Bulbuller, PB Kirmizibayrak, M Gul, A Angeli, S Bua, ...
Bioorganic chemistry 78, 290-297, 2018
432018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20